- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07257991
Comparison of Dressing Materials of Donor Site of Split-thickness Skin Graft; Paraffin Mesh Gauze vs Povidone-Iodine Foam at SMBB Institute of Trauma Karachi
The goal of this clinical trial is to learn if povidone-iodine foam dressing is better in achieving complete reepithelialization of donor site wounds after harvest of split-thickness skin graft as paraffin mesh gauze.
The main questions it aims to answer are:
Does povidone-iodine foam dressing promotes complete reepithelialization earlier in comparison? Which type of dressing will require fewer replacements? Which type of dressing material is associated with less pain?
Non-probability consecutive sampling method will be used and participants divided in two groups. Donor site wounds after split-thickness skin graft harvest will be dressed using two different dressing materials. Participants will be followed until complete epithelialization with change of dressing on follow-ups if required. Complete epithelialization is usually achieved within two weeks.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Undergoing skin graft with donor site size between 25 to 200 cm2
Exclusion Criteria:'
- Patients wit history of disease impairing wound healing (Diabetes, Malignancy, Cancer, taking immunosuppressants)
- Pregnant or lactating females
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PG GROUP
Paraffin gauze dressing will be used.
|
A sterile paraffin-impregnated mesh gauze dressing will be applied directly over the donor site under aseptic conditions.
The dressing will be covered with sterile secondary gauze and secured with crepe bandage.
The initial dressing will be left undisturbed for 7 days unless early change is required for bleeding, leakage, or infection.
The donor site will be assessed on day 7 and every alternate day thereafter until complete re-epithelialization, and the dressing will be changed only if clinically indicated.
|
|
Experimental: PI GROUP
Povidone-iodine foam dressing will be used in this group.
|
A sterile, medical-grade open-cell polyurethane foam will be cut to fit the split-thickness skin graft donor site and soaked in 3% povidone-iodine solution immediately before application. The foam dressing will be applied to the donor site under aseptic conditions and secured with a sterile secondary dressing of gauze and crepe bandage. The initial dressing will be left undisturbed for 7 days unless early change is required due to bleeding, leakage, loosening, or signs of infection. The donor site will first be assessed on day 7, and subsequently every alternate day until complete re-epithelialization. At each assessment, the dressing will be changed only if clinically indicated. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of patients with complete reepithelialization at day 14
Time Frame: From the day of procedure till complete reepithelialization, nearly 14 days
|
Measurement name is percentage of patients.
Measurement tool will be clinical observation/ visual assessment by principal investigator defined as 100% wound healing.
|
From the day of procedure till complete reepithelialization, nearly 14 days
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB000195/SMBBIT/Approval/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Graft Wounds
-
Hospital Universiti Sains MalaysiaCompletedSkin Graft WoundsMalaysia
-
Federico II UniversityRecruitingWounds and Injuries | Skin Graft Scar | Skin Graft ComplicationsItaly
-
Rion Inc.ProPharmaActive, not recruiting
-
Centre Hospitalier Universitaire VaudoisCompleted
-
PT. Daewoong InfionEquilab InternationalCompletedSkin Graft Scar | Split-Thickness Skin Graft (STSG)Indonesia
-
Loma Linda UniversityWithdrawnSkin Graft Complications
-
University of Sao PauloUnknownBurn | Skin GraftBrazil
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompletedMorality | Skin Graft ComplicationsChina
-
Milliken Healthcare Products, LLCU.S. Army Medical Research and Development Command; Criterium, Inc.CompletedBurns | Skin Burn Requiring Skin GraftUnited States
-
Solventum US LLC3MWithdrawnSkin Graft | Split Thickness Skin Graft | Skin Cancer Excision SiteUnited States
Clinical Trials on Paraffin mesh gauze dressing for donor site of Split-thickness skin graft
-
Tang-Du HospitalCompletedDisorder of Skin Donor Site | Skin Graft Disorder | Wound Healing Disturbance of
-
University of British ColumbiaRecruiting